These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7794705)

  • 1. Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?
    Somers M; Kertesz S; Rosen S; Herrin J; Colvin R; Palacios de Carreta N; Kim M
    Pediatr Nephrol; 1995 Apr; 9(2):140-4. PubMed ID: 7794705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?
    Fujita T; Nozu K; Iijima K; Kamioka I; Yoshiya K; Tanaka R; Hamahira K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Nephrol; 2006 Feb; 21(2):194-200. PubMed ID: 16247645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in children with membranoproliferative glomerulonephritis type I.
    García-de la Puente S; Orozco-Loza IL; Zaltzman-Girshevich S; de Leon Bojorge B
    Pediatr Nephrol; 2008 Jun; 23(6):929-35. PubMed ID: 18297315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis.
    Çaltik Yilmaz A; Aydog Ö; Akyüz SG; Bülbül M; Demircin G; Öner A
    Ren Fail; 2014 Sep; 36(8):1221-5. PubMed ID: 25065413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC; West CD; Strife CF
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO; Gbadegesin RA; Adeyemo AA; Akang EE; Arowolo FA; Abiola OA; Osinusi K
    West Afr J Med; 1999; 18(3):203-6. PubMed ID: 10593158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
    Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989.
    McEnery PT
    J Pediatr; 1990 May; 116(5):S109-14. PubMed ID: 2329412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.
    Bergstein JM; Andreoli SP
    Pediatr Nephrol; 1995 Jun; 9(3):268-71. PubMed ID: 7632508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome.
    Nishi S; Ueno M; Shimada H; Oosawa Y; Iino N; Iguchi S; Karasawa R; In H; Kawashima S; Saito N; Imai N; Saito K; Suzuki S; Arakawa M; Gejyo F
    Intern Med; 2000 Oct; 39(10):788-93. PubMed ID: 11030201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy.
    Ford DM; Briscoe DM; Shanley PF; Lum GM
    Kidney Int; 1992 Jun; 41(6):1606-12. PubMed ID: 1501416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of resistant MPGN type I with mycophenolate mofetil and steroids.
    De S; Al-Nabhani D; Thorner P; Cattran D; Piscione TD; Licht C
    Pediatr Nephrol; 2009 Mar; 24(3):597-600. PubMed ID: 18972137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID).
    Lagrue G; Laurent J; Belghiti D
    Int Urol Nephrol; 1988; 20(6):669-77. PubMed ID: 3229937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic membranoproliferative glomerulonephritis in Japanese children.
    Iitaka K; Ishidate T; Hojo M; Kuwao S; Kasai N; Sakai T
    Pediatr Nephrol; 1995 Jun; 9(3):272-7. PubMed ID: 7632509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of the classification system for membranoproliferative glomerulonephritis.
    Lu Y; Shen P; Li X; Xu Y; Pan X; Wang W; Chen X; Zhang W; Ren H; Chen N
    Contrib Nephrol; 2013; 181():175-84. PubMed ID: 23689579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.